Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin–meropenem combination therapy for multidrug-resistant Gram-negative bacterial infections

This publication has 12 references indexed in Scilit:

• Combination Therapy with Intravenous Colistin for Management of Infections Due to Multidrug-Resistant Gram-Negative Bacteria in Patients without Cystic Fibrosis
  Antimicrobial Agents and Chemotherapy, 2005
• Combined colistin and rifampicin therapy for carbapenem-resistant Acinetobacter baumannii infections: clinical outcome and adverse events
  Clinical Microbiology and Infection, 2005
• Colistin: The Revival of Polymyxins for the Management of Multidrug-Resistant Gram-Negative Bacterial Infections
  Clinical Infectious Diseases, 2005
• Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic
  Clinical Microbiology and Infection, 2005
• Use of colistin in the treatment of multiple-drug-resistant gram-negative infections
  American Journal of Health-System Pharmacy, 2005
• Year in review in intensive care medicine: 2003. II. Brain injury, hemodynamics, gastrointestinal tract, renal failure, metabolism, trauma, and postoperative
  Intensive Care Medicine, 2004
• Microbiological Activity and Clinical Efficacy of a Colistin and Rifampin Combination in Multidrug-ResistantPseudomonas aeruginosaInfections
  Journal of Chemotherapy, 2004
• In vitro and in vivo synergistic activity of colistin, rifampin, and amikacin against a multiresistant Pseudomonas aeruginosa isolate
  Clinical Microbiology and Infection, 2000
• Safety and Tolerability of Bolus Intravenous Colistin in Acute Respiratory Exacerbations in Adults with Cystic Fibrosis
  Annals of Pharmacotherapy, 2000
• The Effect of Acute Renal Failure on Mortality
  JAMA, 1996